Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation

Blood

Volumn 95, Issue 11, 2000, Pages 3548-3554

  Condino Neto, Antonio ^b   Newburger, Peter E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; DRUG EFFECT; ELECTRON TRANSPORT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INTRON; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RNA SPLICING;

EID: 0034210624     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3548     Document Type: Article

References (59)

1. Dinauer MC, Nauseel WM, Newburger PE. Inherited disorders of phagocyte killing. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B, eds. The Metabolic and Molecular Basis of Inherited Disease. 8th ed. New York, NY; McGraw-Hill. In press.
2. Malech HL, Nauseef WM. Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol. 1997;34:279-290.
3. Thrasher AJ, Keep NH, Wientjes F, Segal AW. Chronic granulomatous disease. Biochim Biophys Acta Mol Basis Dis. 1994;1227:1-24.
4. Dinauer MC. The phagocyte system and disorders of granulopoiesis and granulocyte function. In: Nathan DG, Orkin ST. eds. Hematology of Infancy and Childhood. Philadelphia, PA: WB Saunders; 1998:889-920.
5. 245 in chronic granulomatous disease: a multicenter European evaluation of its incidence and relevance. N Engl J Med. 1983; 308:245-251.
6. Royer-Pokora B, Kunkel LM, Monaco AP. et al. Cloning the gene for an inherited disorder -chronic granulomatous disease - on the basis of its chromosomal location. Nature. 1986;322: 32-38.
7. Parkos CA, Dinauer MC, Walker LE, Allen RA, Jesaitis AJ, Orkin SH. The primary structure and unique expression of the 22 kilodalton light chain of human neutrophil cytochrome b. Proc Natl Acad Sci USA. 1988;85:3319-3323.
8. Skalnik DG, Strauss EC, Orkin SH. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91 -phox gene promoter. J Biol Chem. 1991;266:16,736-16,744.
9. Rae J, Newburger PE, Dinauer MC, et al. X-linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of the respiratory burst oxidase. Am J Hum Genet. 1998;62:1320-1331.
10. Roos D, de Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 1996;87:1663-1681.
11. De Boer M, Bolscher BGJM, Dinauer MC, et al. Splice site mutations are a common cause of X-linked chronic granutomatous disease. Blood. 1992;80:1553-1558.
12. Lew PD, Southwick FS, Stossel TP, Whitin JC, Simons ER, Cohen HJ. A variant of chronic granulomatous disease: deficient oxidative metabolism due to a low-affinity NADPH oxidase. N Engl J Med. 1981;305:1329-1333.
13. Newburger PE, Luscinskas FW, Ryan T, et al. Variant chronic granulomatous disease: modulation of the neutrophil defect by severe infection. Blood. 1986;68:914-919.
14. Condino-Neto A, Rae J, Padden C, Whitney C, Curnutte JT, Newburger PE. An intronic mutation in CYBB gene leading to RNA instability and variant X-linked chronic granulomatous disease [abstract]. Blood. 1997;90:599.
15. Ezekowitz RAB, Orkin SH, Newburger PE. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J Clin Invest. 1987;80:1009-1016.
16. Ezekowitz RAB, Dinauer MC, Jaffe HS, Orkin SH, Newburger PE. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med. 1988;319:146-151.
17. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968;21(suppl 97):1-77.
18. Nilsson K, Klein G, Henle W, Henle G. The establishment of lymphoblastoid cell lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer. 1971;8:443-450.
19. Volkman DJ, Buescher ES, Gallin JI, Fauci AS. B cell lines as models for inherited phagocytic diseases: superoxide generation in chronic granulomatous disease and granules in Chediak-Higashi syndrome. J Immunol. 1984;133:3006-3009.
20. Corcione A, Ottonello L, Tortolina G, et al. Recombinant tumor necrosis factor enhances the locomotion of memory and naive B lymphocytes from human tonsils through the selective engagement of the type II receptor. Blood. 1997;90:4493-4501.
21. Jouanguy E, Lamhamedi-Cherradi S, Altare F, et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest. 1997;100:2658-2664.
22. Condino-Neto A, Whitney C Newburger PE. Dexamethasone but not indomethacin down-regulates the human NADPH oxidase by inhibiting the expression of genes encoding components of the NADPH oxidase system. J Immunol. 1998;161:4960-4967.
23. Newburger PE, Dai Q, Whitney C. In vitro regulation of human phagocyte cytochrome b heavy and light chain gene expression by bacterial lipopolysaccharide and recombinant human cytokines. J Biol Chem. 1991;266:16,171-16,177.
24. Newburger PE, Ezekowitz RAB, Whitney C, Wright J, Orkin SH. Induction of phagocyte cytochrome b heavy chain gene expression by Interferon gamma. Proc Natl Acad Sci U S A. 1988;85: 5215-5219.
25. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324:509-5160.
26. Subrahmanyam YBK, Baskaran N, Newburger PE, Weissman SM. A modified method for the display of 3′-end restriciton fragments of cDNAs: molecular profiling of gene expression in neutrophils. Methods Enzymol. 1999;303:272-297.
27. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1990.
28. Lomax KJ, Leto TL, Nunoi H, Gallin JI. Malech HL. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science. 1989;245:409-412.
29. Gatti RA, Concannon P, Salser W. Multiple use of Southern blots. Biotechniques. 1984;2:148-155.
30. Katz RA, Erlanger BF, Guntaka RV. Evidence for extensive methylation of ribosomal RNA genes in a rat XC cell line. Biochim Biophys Acta. 1983; 739:258-264.
31. Newburger PE, Speier C, Borregaard N, Walsh CE, Whitin JC, Simons ER. Development of the superoxide-generating system during differentiation of the HL-60 promyelocytic leukemia cell line. J Biol Chem. 1984;259:3771-3776.
32. 558 content of human Epstein-Barr virus transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system. Arch Biochem Biophys. 1998;360:158-164.
33. Greenberg ME, Greene LA, Ziff EB. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J Biol Chem. 1985;260:14,101-14,110.
34. Krowczynska A, Yenofsky R, Brawerman G. Regulation of messenger RNA stability in mouse erythroleukemia cells. J Mol Biol. 1985;181:231-239.
35. Bhattacharyya GK, Johnson RA. Nonparametric inference. In: Bhattacharyya GK, Johnson RA, eds. Statistical Concepts and Methods. Singapore: John Wiley; 1977:505-547.
36. Hashinaka K, Nishio C, Hur S, Sakiyama F, Tsunasawa S, Yamada M. Multiple species of myeloperoxidase messenger RNAs produced by alternative splicing and differential polyadenylation. Biochemistry. 1988;27:5906-5914.
37. Kornblihtt AR, Pesce CG, Alonso CR, et al. The fibronectin gene as a model for splicing and transcription studies. FASEB J. 1996;10:248-257.
38. Bayes M, Hartung AJ, Ezer S, et al. The anhidrotic ectodermal dysplasia gene (EDA) undergoes alternative splicing and encodes ectodysplasin-A with deletion mutations in collagenous repeats. Hum Mol Genet. 1998;7:1661-1669.
39. Cichon S, Anker M, Vogt IR, et al. Cloning, genomic organization, alternative transcripts and mutational analysis of the gene responsible for autosomal recessive universal congenital alopecia. Hum Mol Genet. 1998;7:1671-1679.
40. Kojima T, Horiuchi T, Nishizaka H, et al. Genetic basis of human complement C8alpha-gamma deficiency. J Immunol. 1998;161:3762-3766.
41. Tabata Y, Isashiki Y, Kamimura K, Nakao K, Ohba N. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorby's fundus dystrophy with unusual clinical features. Hum Genet. 1998;103:179-182.
42. 245 components by human tonsillar B lymphocytes and B cell lines. J Immunol. 1989;142:1260-1267.
43. Ezekowitz RAB, Sieff CA, Dinauer MC, Nathan DG, Orkin SH, Newburger PE. Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood. 1990;76: 2443-2448.
44. Woodman RC, Erickson RW, Rae J, Jaffe HS, Curnutte JT. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Blood. 1992;79:1558-1562.
45. Bemiller LS, Roberts DH, Starko KM, Curnutte JT. Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease. Blood Cells Mol Dis. 1995;21:239-247.
46. Yagisawa M, You A, Yonemaru M, et al. Superoxide release and NADPH oxidase components in mature human phagocytes: correlation between functional capacity and amount of functional proteins. Biochem Biophys Res Commun. 1996;228: 510-516.
47. Forehand JR, Pabst MJ, Phillips WA, Johnston RB Jr. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst: role of intracellular free calcium J Clin Invest. 1989;83: 74-83.
48. Berkow RL, Dodson MR. Biochemical mechanisms involved in the priming of neutrophils by tumor necrosis factor. J Leukoc Biol. 1988;44: 345-352.
49. Johnston JJ, Rintels P, Chung J, Sather J, Benz EJ Jr, Berliner N. Lactoferrin gene promoter: structural integrity and nonexpression in HL60 cells. Blood. 1992;79:2998-3006.
50. Woodman RC, Curnutte JT, Babior BM. Evidence that de novo protein synthesis participates in a time-dependent augmentation of the chemotactic peptide-induced respiratory burst in neutrophils. Free Radic Biol Med. 1988;5:355-361.
51. 245 heavy chain gene expression and nicotinamide-adenine dinucleotide phosphate oxidase in human leukemic myeloid cells. J Clin Invest. 1989;83:1570-1579.
52. Yao XL, Ikezono T, Cowan M, Logun C, Angus CW, Shelhamer JH. Interferon-gamma stimulates human Clara cell secretory protein production by human airway epithelial cells. Am J Physiol. 1998;274:L864-L869.
53. Mitchell TJ, Naughton M, Norsworthy P, Davies KA, Walport MJ, Morley BJ. IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. J Immunol. 1996;156:4429-4434.
54. Lappin DF, Guc D, Hill A, McShane T, Whaley K. Effect of interferon-gamma on complement gene expression in different cell types. Biochem J. 1992;281:437-442.
55. Lappin DF, Whaley K. Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes. Biochem J. 1990;271:767-772.
56. Ohh M, Takei F. Interferon-gamma- and phorbol myristate acetate-responsive elements involved in intercellular adhesion molecule-1 mRNA stabilization. J Biol Chem. 1994;269:30,117-30,120.
57. Ohh M, Smith CA, Carpenito C, Takei F. Regulation of intercellular adhesion molecule-1 gene expression involves multiple mRNA stabilization mechanisms: effects of interferon-gamma and phorbol myristate acetate. Blood. 1994;84:2632-2639.
58. Suk K, Erickson KL. Differential regulation of tumour necrosis factor-alpha mRNA degradation in macrophages by interleukin-4 and interferon-gamma. Immunology. 1996;87:551-558.
59. Tolstrup AB, Bejder A, Fleckner J, Justesen J. Transcriptional regulation of the interferon-gamma-inducible tryptophanyl-tRNA synthetase includes alternative splicing. J Biol Chem. 1995; 270:397-403.